Terms: = Bone cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Treatment
253 results:
1. RANK/RANKL axis promotes migration, invasion, and metastasis of osteosarcoma via activating NF-κB pathway.
Takeda T; Tsubaki M; Genno S; Tomita K; Nishida S
Exp Cell Res; 2024 Mar; 436(2):113978. PubMed ID: 38382805
[TBL] [Abstract] [Full Text] [Related]
2. Inhibition of anlotinib-induced autophagy attenuates invasion and migration by regulating epithelial-mesenchymal transition and cytoskeletal rearrangement through ATG5 in human osteosarcoma cells.
Zheng B; Sun X; Zhang L; Qu G; Ren C; Yan P; Zhou C; Yue B
Braz J Med Biol Res; 2024; 57():e13152. PubMed ID: 38381883
[TBL] [Abstract] [Full Text] [Related]
3. AEBP1 promotes papillary thyroid cancer progression by activating BMP4 signaling.
Ju G; Xing T; Xu M; Zhang X; Sun Y; Mu Z; Sun D; Miao S; Li L; Liang J; Lin Y
Neoplasia; 2024 Mar; 49():100972. PubMed ID: 38237535
[TBL] [Abstract] [Full Text] [Related]
4. bone morphogenetic protein-9 downregulates StAR expression by inducing snail expression via SMAD1/5/8 signaling in human granulosa-lutein cells.
Liu B; Fu B; Zhou S; Wang H; Bi B; Guo M; Cheng JC; Fang L
Mol Cell Endocrinol; 2024 Mar; 582():112126. PubMed ID: 38109991
[TBL] [Abstract] [Full Text] [Related]
5. Role of non-coding RNAs as new therapeutic targets in regulating the emt and apoptosis in metastatic gastric and colorectal cancers.
Ebrahimi N; Hakimzadeh A; Bozorgmand F; Speed S; Manavi MS; Khorram R; Farahani K; Rezaei-Tazangi F; Mansouri A; Hamblin MR; Aref AR
Cell Cycle; 2023 Oct; 22(20):2302-2323. PubMed ID: 38009668
[TBL] [Abstract] [Full Text] [Related]
6. Machine learning based on SPECT/CT to differentiate bone metastasis and benign bone lesions in lung malignancy patients.
Wang H; Chen Y; Qiu J; Xie J; Lu W; Ma J; Jia M
Med Phys; 2024 Apr; 51(4):2578-2588. PubMed ID: 37966123
[TBL] [Abstract] [Full Text] [Related]
7. Deregulated MicroRNAs involved in P53 Signaling Pathway in Breast cancer with Focus on Triple-negative Breast cancer.
Naeimzadeh Y; Heidari Z; Razban V; Khajeh S
Curr Mol Pharmacol; 2024; 17(1):e18761429263841. PubMed ID: 37916633
[TBL] [Abstract] [Full Text] [Related]
8. Arctigenin Suppresses the Proliferation and Metastasis, and Induces Apoptosis and Cycle Arrest of Osteosarcoma Cells by inhibiting HMOX1 Expression.
Xu G; He Z; Liu Y
Anticancer Agents Med Chem; 2023; 23(20):2209-2216. PubMed ID: 37711016
[TBL] [Abstract] [Full Text] [Related]
9. Synergistic anti-tumour activity of ginsenoside Rg3 and doxorubicin on proliferation, metastasis and angiogenesis in osteosarcoma by modulating mTOR/HIF-1α/VEGF and emt signalling pathways.
Zeng X; Liu S; Yang H; Jia M; Liu W; Zhu W
J Pharm Pharmacol; 2023 Nov; 75(11):1405-1417. PubMed ID: 37498992
[TBL] [Abstract] [Full Text] [Related]
10. bone morphogenetic protein (BMP)9 in cancer development: mechanistic, diagnostic, and therapeutic approaches?
Alkhathami AG; Abdullah MR; Ahmed M; Hassan Ahmed H; Alwash SW; Muhammed Mahdi Z; Alsaikhan F; Dera AA
J Drug Target; 2023 Aug; 31(7):714-724. PubMed ID: 37461888
[TBL] [Abstract] [Full Text] [Related]
11. Solasonine Inhibits cancer Stemness and Metastasis by Modulating Glucose Metabolism via Wnt/β-Catenin/Snail Pathway in Osteosarcoma.
Wang B; Zhou Y; Zhang P; Li J; Lu X
Am J Chin Med; 2023; 51(5):1293-1308. PubMed ID: 37367817
[TBL] [Abstract] [Full Text] [Related]
12. Nε-(1-Carboxymethyl)-L-lysine, an advanced glycation end product, exerts malignancy on chondrosarcoma via the activation of cancer stemness.
Chang TY; Lan KC; Wu CH; Sheu ML; Yang RS; Liu SH
Arch Toxicol; 2023 Aug; 97(8):2231-2244. PubMed ID: 37314482
[TBL] [Abstract] [Full Text] [Related]
13. Acute myeloid leukemia (AML)-derived mesenchymal stem cells induce chemoresistance and epithelial-mesenchymal transition-like program in AML through IL-6/JAK2/STAT3 signaling.
Lu J; Dong Q; Zhang S; Feng Y; Yang J; Zhao L
Cancer Sci; 2023 Aug; 114(8):3287-3300. PubMed ID: 37272257
[TBL] [Abstract] [Full Text] [Related]
14. Deubiquitinating enzyme USP10 promotes osteosarcoma metastasis and epithelial-mesenchymal transition by stabilizing YAP1.
Deng J; Yi X; Feng Z; Peng J; Li D; Li C; Deng B; Liu S; Sahu S; Hao L
Cancer Med; 2023 Jul; 12(13):14452-14467. PubMed ID: 37184153
[TBL] [Abstract] [Full Text] [Related]
15.
Wang K; Chu Y; Zhang H; Qu X; Wang B; Han Y
Comb Chem High Throughput Screen; 2024; 27(3):436-445. PubMed ID: 37151068
[TBL] [Abstract] [Full Text] [Related]
16. Myeloid-like tumor hybrid cells in bone marrow promote progression of prostate cancer bone metastasis.
Ye X; Huang X; Fu X; Zhang X; Lin R; Zhang W; Zhang J; Lu Y
J Hematol Oncol; 2023 May; 16(1):46. PubMed ID: 37138326
[TBL] [Abstract] [Full Text] [Related]
17. Effects of CCN6 overexpression on the cell motility and activation of p38/bone morphogenetic protein signaling pathways in pancreatic cancer cells.
Nam MW; Lee HK; Kim CW; Choi Y; Ahn D; Go RE; Choi KC
Biomed Pharmacother; 2023 Jul; 163():114780. PubMed ID: 37105075
[TBL] [Abstract] [Full Text] [Related]
18. Cellular Transcriptomics of Carboplatin Resistance in a Metastatic Canine Osteosarcoma Cell Line.
Hodge MA; Miller T; Weinman MA; Wustefeld-Janssens B; Bracha S; Davis BW
Genes (Basel); 2023 Feb; 14(3):. PubMed ID: 36980828
[TBL] [Abstract] [Full Text] [Related]
19. DEPDC1 and KIF4A synergistically inhibit the malignant biological behavior of osteosarcoma cells through Hippo signaling pathway.
Yang M; Zhang H; Gao S; Huang W
J Orthop Surg Res; 2023 Feb; 18(1):145. PubMed ID: 36849972
[TBL] [Abstract] [Full Text] [Related]
20. Nitazoxanide inhibits acetylated KLF5-induced bone metastasis by modulating KLF5 function in prostate cancer.
Huang Q; Liu M; Zhang D; Lin BB; Fu X; Zhang Z; Zhang B; Dong JT
BMC Med; 2023 Feb; 21(1):68. PubMed ID: 36810084
[TBL] [Abstract] [Full Text] [Related]
[Next]